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Abstract: 
Peak cough flow (PCF) measurements can be used as indicators of cough 
effectiveness. Portable peak flow meters and spirometers have been used 
to measure PCF, but little is known about their accuracy compared to 
laboratory based pneumotachograph systems. We compared the accuracy 
of four portable devices (Mini-Wright and Assess peak flow meters, 
SpiroUSB and Microlab spirometers) in measuring PCF with a calibrated 
laboratory based pneumotachograph system. Twenty healthy volunteers 
(mean (SD) age 45 (16)) coughed through a pneumotachograph connected 
in series with each portable device in turn, and the difference in PCF 
readings was analysed. In addition, mechanically generated flow waves of 
constant peak flow were delivered through each device both independently 
and when connected in series with the pneumotachograph. Agreement 
between PCF readings obtained with the pneumotachograph and the 
portable devices was poor. Peak flow readings were lower when measured 
using the portable devices, for both volitional coughs and mechanically 
generated flow waves; 95% limits of agreement spanned approximately 
150 L/min. Of the four portable devices examined none were sufficiently 
accurate for the measurement of PCF. Depending on the measurement 
method used, absolute values of PCF reported in the literature may not be 
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Peak cough flow (PCF) measurements can be used as indicators of cough effectiveness. Portable peak 
flow meters and spirometers have been used to measure PCF, but little is known about their accuracy 
compared to laboratory based pneumotachograph systems. We compared the accuracy of four 
portable devices (Mini-Wright and Assess peak flow meters, SpiroUSB and Microlab spirometers) in 
measuring PCF with a calibrated laboratory based pneumotachograph system. Twenty healthy 
volunteers (mean (SD) age 45 (16)) coughed through a pneumotachograph connected in series with 
each portable device in turn, and the difference in PCF readings was analysed. In addition, 
mechanically generated flow waves of constant peak flow were delivered through each device both 
independently and when connected in series with the pneumotachograph. Agreement between PCF 
readings obtained with the pneumotachograph and the portable devices was poor. Peak flow readings 
were lower when measured using the portable devices, for both volitional coughs and mechanically 






























































generated flow waves; 95% limits of agreement spanned approximately 150 L/min. Of the four 
portable devices examined none were sufficiently accurate for the measurement of PCF. Depending 
on the measurement method used, absolute values of PCF reported in the literature may not be 
directly comparable.  
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1. Introduction 
Cough flow testing is useful as an outcome measure in research and a monitoring or diagnostic tool in 
clinical practice. Peak cough flow (PCF) is commonly used as an indicator of the strength or 
effectiveness of cough, particularly in clinical populations with neuromuscular impairment (Jones et 
al 2012). Cough can be accurately quantified using laboratory pneumotachograph based systems as 
described by Singh et al (1994), but these can often consist of several components, can be expensive, 
not easily transportable, and require significant knowledge by the user for correct operation. Practical 
devices, which can conveniently be applied in clinical settings, patients’ homes or other community 
locations, may be of use to clinicians and researchers. In several clinical studies, standard peak flow 
meters and hand-held spirometers have been used to measure PCF (Table 1) (LoMauro et al 2014, 
Silverman et al 2014, Cleary et al 2013, Kimura et al 2013, Lee et al 2013, Cardoso et al 2012, 
Freitas et al 2010, Brito et al 2009, Fiore et al 2008, Daftary et al 2007, Sancho et al 2007, Bach et al 
2006, Dohna-Schwake et al 2006, Kang et al 2006, Gauld and Boynton 2005, Sancho et al 2004, 
Suarez et al 2002, Bach et al 1997, Bach and Saporito 1996, Bach 1995, Leiner et al 1966, Wright 
and McKerrow 1959). These devices are designed to measure peak flow during a forced expiratory 
manoeuvre, and their accuracy in measuring peak flow during cough is uncertain.  
 
In the present study we examined the accuracy of two commonly used peak flow meters and two 
hand-held spirometers when measuring PCF compared with a laboratory pneumotachograph based 
measurement system.  
 
2. Materials and Methods 
2.1. Study subjects 
Healthy volunteers with no medical history of respiratory disease or conditions affecting the anatomy 
and function of the upper airway who were comfortable coughing repeatedly over a short period of 
time were recruited. The study had ethical approval from the Psychiatry, Nursing and Midwifery 






























































Research Ethics Committee at King’s College London, United Kingdom (study reference 
PNM/12/13-143). All participants gave written informed consent.  
 
2.2. Study design 
Four hand-held devices were compared to a laboratory pneumotachograph based flow measurement 
system: the Mini-Wright Standard peak flow meter (European Union (EU) Scale, range 60-800 L/min, 
accuracy ±10% or 10 L/min according to manufacturer, Clement Clarke International, Harlow, 
England); Assess peak flow meter (range 60-880 L/min, accuracy ±10% or 20 L/min according to 
manufacturer, Philips Respironics, Pittsburgh, Pennsylvania); SpiroUSB turbine spirometer, (range 
12-900 L/min, accuracy ±3% according to manufacturer, CareFusion, San Diego, California); and the 
Microlab turbine spirometer, (range 12-900 L/min, accuracy ±3% according to manufacturer, 
CareFusion, San Diego, California). These four devices were selected as they are produced by leading 
manufacturers and frequently used in clinical practice.  
 
The devices under test were attached individually to a Fleisch-type pneumotachograph (ID 4.4 cm, 
length 6.0 cm, PK Morgan Ltd, Rainham, England). Differential pressure was measured using a 
Validyne differential pressure transducer (MP45, range ± 2 cmH2O, Validyne Engineering, 
Northridge, California) and the signal amplified (CD15, Validyne Engineering, Northridge, 
California) and acquired on a laptop running LabChart software (LabChart Pro, version 7.2.2, 
ADInstruments Ltd, Oxford, England) with analog-to-digital sampling of 2 kHz (PowerLab/16SP, 
ADInstruments Ltd, Oxford, England). The pneumotachograph system was linear in the flow range 0-
700 L/min (R2 = 0.999845) and had a frequency response of 50 Hz. A two-point calibration was 
performed at the beginning of each testing session, using a rotameter (InFlux OF1”S, 60-600 L/min 
flow, Techniquip Ltd, Taunton, England).  
 
2.3. Methods 
A bacterial filter (Spiroguard Standard, Air Safety Medical, Morecambe, England), the 
pneumotachograph and one portable device were connected in series. Participants were instructed to 






























































cough through the filter so that the peak flow of each cough was measured by the pneumotachograph 
system and the portable device. The portable devices were tested in a random order and were always 
connected downstream from the pneumotachograph. The calibration of the SpiroUSB and the 
Microlab turbine spirometers was verified with a 3 litre calibration syringe at the beginning of each 
testing session as per manufacturer’s recommendation. For each device, volunteers were instructed to 
produce five strong coughs (from total lung capacity), five weak coughs (from residual volume) and 
five coughs of subjectively moderate strength (between strong and weak cough efforts). Participants 
were seated during testing. Altogether, 300 coughs were measured per portable device.  
Volunteers also performed spirometric forced expiratory manoeuvres through the pneumotachograph 
with each portable device connected in series in random order. One hundred maximal and 100 
subjectively submaximal forced expiratory manoeuvres were measured per portable device, giving a 
range of expiratory flows during forced expiration without glottic closure.  
In order to control for any systematic effect on cough flow measurements caused by the in-series 
connection of pneumotachograph and alternative device, flow waves of consistent peak flow were 
mechanically generated using a 50 L pressure vessel (Medical Engineering Department, Royal 
Brompton Hospital, London, England) connected to a balloon occlusion valve (Medical Engineering 
Department, Royal Brompton Hospital, London, England). The barrel was pressurised with 
compressed air to a predetermined pressure, monitored with a digital manometer (C9553 Pressure 
Meter, Comark, Norwich, England), at which point the occlusion valve was opened and a burst of 
short duration airflow released. The consistency of peak flow for these flow bursts was confirmed 
with five consecutive measurements with the pneumotachograph system. Vessel pressures of 5, 10, 
15, 20, 30 and 40 cmH2O were used, resulting in bursts of airflow with mean (SD) peak flows of 138 
(0.4), 250 (1.3), 343 (0.8), 422 (0.8), 559 (1.6) and 684 (2.9) L/min, respectively. Using the 
mechanically produced airflows, the agreement of peak flow measurements between systems was 
deteremined with the pneumotachograph and alternative devices connected in series (identical setup 
as used for volunteers, including bacterial filter); and with pneumotachograph and alternative devices 
connected in isolation (including bacterial filter). Five measurements were made at each flow level for 
each portable device connected in series and in isolation.  
































































Data were analysed using statistical software (Stata version 12.1, StataCorp LP, College Station, 
Texas). Bland-Altman analysis was used to compare peak flow measurements obtained from the 
pneumotachograph and each device for both measurements of volitional PCF, peak flow obtained 
from forced expiratory manoeuvres and the mechanically generated flow waves with devices used in 
series and in isolation.  
 
3. Results 
Twenty volunteers, mean (SD) age 45 (16), were studied, with at least one female and one male 
participant per age decade. The mean differences and 95% limits of agreement for volunteers’ PCF 
obtained with the pneumotachograph system and the four portable devices are summarised in Table 2. 
Bland-Altman analysis indicated that measurements of PCF were lower with the devices tested 
compared with the pneumotachograph system (Figure 1). Measurements of PCF were markedly lower 
using the Mini-Wright peak flow meter (mean (95% limits of agreement) bias 56 L/min (-26 to 138 
L/min)) (Figure 1a), with the difference increasing with increasing PCF (Spearman’s rank correlation 
coefficient rs = 0.38, p <0.0001). Despite a small overall mean (95% limits of agreement) bias of 3 
L/min (-76 to 82 L/min) across the range (Figure 1b), PCFs measured using the Assess device were 
lower than the pneumotachograph system at low PCF and higher at high PCF (rs = -0.46, p <0.0001). 
Both the SpiroUSB (mean (95% limits of agreement) bias 50 L/min (-26 to 125 L/min)) (Figure 1c) 
and the Microlab spirometers (mean (95% limits of agreement) bias 55 L/min (-23 to 132 L/min)) 
(Figure 1d) returned PCF readings that were consistently lower than those measured using the 
pneumotachograph system.  
Some coughs with low peak flows were not registered by the portable devices and were excluded 
from the Bland Altman analysis. The Mini-Wright and Assess peak flow meters did not register 15 
coughs with PCF between 60 L/min (lowest mark on the devices’ scale) and 118 L/min, as measured 
by the pneumotachograph. Thirty-four coughs with PCF from 89 to 207 L/min were not registered by 






























































the SpiroUSB spirometer. Twenty-five coughs with PCF from 58 to 237 L/min were not registered by 
the Microlab spirometer.  
 
The results for the mechanically generated flow waves are presented in Tables 3 and 4 and in Figure 
2. Example traces of mechanically generated flow waves in comparison with human cough flow 
waves are given in Figure 3. All portable devices recorded lower peak flow compared to the 
pneumotachograph system regardless of whether measurements were made when connected in series 
(Table 3) or in isolation (Table 4). The differences in measured peak flow between the 
pneumotachograph and alternative devices were smaller when the instruments were connected in 
series; and larger when the instruments were used in isolation. When instruments were connected in 
series, the pneumotachograph and portable devices all gave lower peak flow readings compared to 
when instruments were used in isolation; whereby measurements were always reduced to a greater 
extent for the pneumotachograph (mean (SD) difference 79 (38) L/min) than for the portable devices 
(mean (SD) difference 9 (6) L/min).  
Correlation analysis to examine the relationship between cough rise time (time from initiation of 
positive flow to peak flow) and the degree of inaccuracy indicated statistically significant weak 
inverse correlations for the Mini-Wright (rs = -0.29, p<0.0001) and the Assess peak flow meter (rs = -
0.28, p<0.0001); and statistically significant moderate inverse correlations for the SpiroUSB (rs = -
0.68, p<0.0001) and the Microlab spirometer (rs = -0.55, p<0.0001) (Figure 4).  
 
Bland-Altman analysis of peak flow measurements during spirometric forced expiratory manoeuvres 
performed with each device connected in series with the pneumotachograph demonstrated a smaller 
bias and narrower limits of agreement compared to those for PCF (Table 5, Figure 5). Similar weak 
and moderate correlations between time to peak flow and the degree of inaccuracy were observed: rs = 
-0.34 (p<0.0001) Mini-Wright peak flow meter, rs = 0.16 (p=0.021) Assess peak flow meter, rs = -0.56 
(p<0.0001) SpiroUSB spirometer, rs = -0.66 (p<0.0001) Microlab spirometer (Figure 6).  
 
4. Discussion 






























































The results of this study indicate that when compared to a laboratory pneumotachograph based 
measurement system, four portable clinical flow measurement devices were inaccurate when 
measuring cough peak flows and returned lower PCF readings. These differences are clinically 
relevant when compared with the magnitude of PCF measurements in clinical populations. In 
addition, some low flow coughs were not registered by these devices, which impacts on their utility in 
very weak or severely obstructed patient populations.  
 
The advantage of a compact, portable and practical clinical flow measurement device over a complex 
pneumotachograph system for the purpose of clinical practice and research is self-evident. This is 
particularly true for clinical populations with neuromuscular conditions, where mobility and 
transportation can be problematic. However, it should not be assumed that portable peak flow meters 
and hand-held spirometers are accurate when used for PCF measurement, as these devices are 
designed to measure peak flow during a forced expiratory manoeuvre. In our measurements of 
mechanically generated flow waves, the portable devices under test showed good instrument 
repeatability, with small standard deviations at each level of flow. It could be argued that good 
instrument repeatability justifies the use of these devices in studies with repeated measures designs. 
However, the accuracy of PCF measurements becomes particularly problematic when patients are 
assessed against absolute thresholds. Clinical guidelines cite PCF thresholds of 160 L/min and 270 
L/min to direct clinical care of patients with neuromuscular conditions (Bott et al 2009, American 
Thoracic Society 2004). A scenario can be envisaged whereby the PCF measured for a patient could 
lie on either side of these threshold values, depending on the measurement device used. Our data 
highlights the importance of considering which measurement device was used to measure PCF when 
interpreting values.  
 
The Mini-Wright and Assess peak flow meters have been used previously for PCF measurement in 
clinical studies (Table 1). The Assess peak flow meter (formerly Access Model 710, Health Scan 
Products Inc, Cedar Grove, New Jersey) was used in the frequently cited clinical studies by Bach and 
collaborators (Bach et al 1997, Bach and Saporito 1996, Bach 1995). To our knowledge, the 






























































SpiroUSB and Microlab spirometers have not previously been used for PCF measurement in clinical 
studies, but a similar turbine-based hand-held spirometer (Spirobank, Medical International Research, 
Rome, Italy) was used in the study by Fiore et al (2008).  
 
Sancho et al (2004) and Silverman et al (2014) have both previously examined the accuracy of 
different portable devices for cough flow testing using repeated maximal cough efforts. This method, 
however, presumes that repeated coughs are sufficiently consistent for intra-subject variability to be 
ignored. Although intra-subject variability may be accounted for by randomising the order of devices, 
and by obtaining repeated measurements within a certain range, for example three maximal coughs 
within 5% PCF as in the study by Sancho et al, intra-subject variability due to fatigue, discomfort, 
motivation, or practice effect remains a limitation of this method, especially with increasing number 
of repetitions. Also, measurements across the mid and lower range of potential values may not be 
assessed conveniently using maximal efforts. The method applied in our study, connecting two 
devices in series, eliminated the problem of intra-subject variability, and allowed the direct 
comparison of coughs across a range of PCF values.  
 
Using mechanically generated flow waves, simulating human expiratory flow waves with consistent 
peak flows, has been used previously to test spirometers and peak flow meters (Miller et al 2005, 
2003). Such an approach allows comparison of measurement devices without the influence of intra-
subject variability or bias due to in-series connection of instruments. The mechanical testing system 
employed in the current study produced flow waves with peak flows and rise times within the range 
observed in human coughs (Sivasothy et al 2001) and indicated greater inaccuracy of PCF 
measurements when using the four devices in isolation. The smaller differences in PCF observed with 
the in series setup is most likely the result of increased air flow resistance causing greater relative 
reductions in pneumotachograph PCF measurements. It is likely, therefore, that the differences in PCF 
measurements between the pneumotachograph and portable devices during coughs in the healthy 
human subjects were also underestimated.  
 






























































In cough, the time to peak flow (rise time) is shorter than during a forced expiratory manoeuvre 
(Miller et al 2002, Sivasothy et al 2001). We theorized that this short rise time may be the critical 
characteristic causing inaccuracies in measurement, as peak flow meters and hand-held spirometers 
may not respond adequately to such a rapid change in signal. Thus, increasing inaccuracy could be 
expected with shorter cough rise time.  Our data partly supports this theory. There was a correlation of 
weak to moderate strength between cough rise time and the inaccuracy in PCF in our human 
volunteers. Similarly, more consistent agreement could be expected for peak flow measurements 
during forced expiratory manoeuvres than during cough, since the portable devices were designed for 
peak flow measurements during forced expiratory manoeuvres. Better agreement was demonstrated 
for peak flow measurements during forced expiratory manoeuvres, more so for the two spirometers 
and the Assess peak flow meter than for the Mini-Wright peak flow meter. The 95% limits of 
agreement were also narrower than for PCF measurements, but still spanned approximately 90 L/min 
for all four portable devices. Of note, the accuracy of hand-held peak flow meters in measuring peak 
flow during forced expiratory manoeuvres has been investigated by others, with devices performing 
variably (Miller et al 2003, Folgering et al 1998). We suggest that rise time is one factor influencing 
accuracy of peak flow measurements, but that further interactions between characteristics of human 
cough and properties of measurement devices impact on the performance of instruments. This 
identifies an interesting area for further investigation.  
 
In order to advance cough flow measurement in clinical research, recommendations based on a 
consensus statement would be of benefit, similar to those produced for the measurement of cough 
frequency and reflex cough sensitivity (Morice et al 2007). Clearly, there is a demand for technology 
that enables scientifically accurate, but also practical and convenient measurement of cough flow. 
Developers of measurement devices should consider the research and clinical conditions such devices 
are likely to be applied in.  
 
5. Conclusions 






























































In conclusion, the four portable flow measurement devices examined in our study did not accurately 
measure PCF. It is important to recognise that, depending on the measurement instrument, absolute 
values of PCF reported in the literature may not be directly comparable. Similarly, peak flow meters 
and hand-held spirometers should be used with caution when measuring PCF in clinical practice, 
particularly in respect to directing patient management.  
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Table 1. Portable peak flow meters and spirometers used for the measurement of peak cough flow in 
clinical research.  
Device Study Study population 
Peak flow meters   
AsmaPLAN (Vitalograph, Ennis, 
Ireland) 
LoMauro et al, 
2014 
Duchenne muscular dystrophy 
Sancho et al, 
2004  
Neuromuscular disease, healthy 
subjects 




Cleary et al, 2013  Amyotrophic lateral sclerosis 
Bach et al, 2006 Restrictive pulmonary syndrome due 
to neuromuscular disease 
Kang et al, 2006 Cervical spinal cord injury 
Bach et al 1997 Duchenne muscular dystrophy 
Bach and Saporito 
1996 
Spinal cord injury, progressive 
neuromuscular disease 
Bach 1995 Amyotrophic lateral sclerosis 
Astech (Astech, New York, New 
York) 
Daftary et al, 
2007 
Duchenne muscular dystrophy 
MicroPeak (Micro Medical Ltd, 
Rochester, England) 
Lee et al, 2013 Traumatic brain injury, healthy 
subjects 
Mini-Wright (Clement Clarke 
International, Harlow, England) 
Silverman et al, 
2014 
Healthy subjects, Parkinson’s disease 
Cardoso et al, 
2012 
Healthy subjects 
Freitas et al, 2010 Healthy elderly subjects 
Brito et al, 2009 Duchenne muscular dystrophy 
Mini-Wright DIGITAL Silver man et al, Healthy subjects, Parkinson’s disease 































































Wright (Wright and McKerrow 1959) Gauld and 
Boynton, 2005 
Duchenne muscular dystrophy 
Leiner et al, 1966 Obstructive and/or restrictive 
pulmonary disease, healthy subjects 
Personal Best (Philips Respironics, 
Pittsburgh, Pennsylvania) 
Suarez et al, 2002 Duchenne muscular dystrophy, 
amyotrophic lateral sclerosis 
Pocketpeak (Ferraris Medical Ltd, 
Enfield, England) 
Dohna-Schwake 
et al, 2006 
Muscular dystrophies 
Spirometers   
Autospiro AS-505 (Minato Medical 
Science, Osaka, Japan) 
Kimura et al, 
2013 
Stroke 
Micro-S 2000 (C. Schatzman, Madrid, 
Spain) 
Sancho et al, 
2007 
Amyotrophic lateral sclerosis 
Spirobank (Medical International 
Research, Rome, Italy) 
Fiore et al, 2008 Cardiac surgery 
a


































































Table 2. Coughs from healthy volunteers: Agreement between peak cough flow measurements 
(Bland-Altman method of analysis) comparing four clinical flow measurement devices with the 
pneumotachograph measurement system.  
Measurement device n 
a
 Mean difference from 
pneumotachograph (bias) b 
L/min 
95% limits of agreement 
L/min 
Mini-Wright peak flow 
meter 
291 56 -26 to 138 
Assess peak flow meter 284 3 -76 to 82 
SpiroUSB spirometer 266 50 -26 to 125 
Microlab spirometer 275 55 -23 to 132 
a
 Number of measurements contributing to analysis, which excludes measurements where the alternative device 
did not return a reading (see text) 
b
 Differences are calculated as pneumotachograph measurements minus alternative device measurements 
 






























































Table 3. Mechanically generated flow waves: Agreement between peak flow measurements (Bland-
Altman method of analysis) with four portable devices connected in series with the 
pneumotachograph measurement system.  
Measurement device n 
a
 Mean difference from 
pneumotachograph (bias) b 
L/min 
95% limits of agreement 
L/min 
Mini-Wright peak flow 
meter 
30 80 0 to 160 
Assess peak flow meter 30 25 4 to 46 
SpiroUSB spirometer 30 58 -2 to 118 
Microlab spirometer 30 54 -5 to 113 
a
 Number of measurements contributing to analysis  
b
 Differences are calculated as pneumotachograph measurements minus alternative device measurements 
 






























































Table 4. Mechanically generated flow waves: Agreement between peak flow measurements (Bland-
Altman method of analysis) recorded from four portable devices and the pneumotachograph 
measurement system in isolation (not connected in series). 
Measurement device n 
a
 Mean difference from 
pneumotachograph (bias) b 
L/min 
95% limits of agreement 
L/min 
Mini-Wright peak flow 
meter 
30 175 54 to 296 
Assess peak flow meter 30 95 37 to 152 
SpiroUSB spirometer 30 115 -8 to 239 
Microlab spirometer 30 112 -8 to 233 
a
 Number of measurements contributing to analysis  
b
 Differences are calculated as pneumotachograph measurements minus alternative device measurements 
 
 






























































Table 5. Forced expiratory manoeuvres from healthy volunteers: Agreement between peak flow 
measurements (Bland-Altman method of analysis) comparing four clinical flow measurement devices 
with the pneumotachograph measurement system.  
Measurement device n 
a
 Mean difference from 
pneumotachograph (bias) b 
L/min 
95% limits of agreement 
L/min 
Mini-Wright peak flow 
meter 
200 41 -6 to 89 
Assess peak flow meter 200 24 -22 to 70 
SpiroUSB spirometer 200 14 -29 to 58 
Microlab spirometer 200 12 -44 to 69 
a
 Number of measurements contributing to analysis 
b
 Differences are calculated as pneumotachograph measurements minus alternative device measurements 
 















































































































































































Figure 1. Coughs by healthy volunteers: Bland-Altman graphs of the agreement in measuring peak 
cough flow (L/min) between the pneumotachograph measurement system and (a) the Mini-Wright 
peak flow meter, (b) the Assess peak flow meter, (c) the SpiroUSB spirometer and (d) the Microlab 
spirometer. The difference between two measurements (pneumotachograph – alternative device) is 
plotted against the mean of two measurements. Solid lines indicate the lines of equality (no difference 
between measurements). Three dashed lines indicate the mean difference between measurements 
(bias) and the upper and lower 95% limits of agreement (bias ± 1.96SD).  
 



































































































































































Figure 2. Mechanically generated flow waves: Agreement in measuring peak flow (L/min) between 
pneumotachograph and (a) Mini-Wright peak flow meter, (b) Assess peak flow meter, (c) SpiroUSB 
spirometer and (d) Microlab spirometer. The difference between two measurements 
(pneumotachograph – alternative device) is plotted against the mean of two measurements. Shown are 
the differences with pneumotachograph and alternative device connected in series (square markers); 
and measurements made with the instruments in isolation (triangular markers).  
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Figure 3. Examples of flow-time plots showing human coughs and mechanically generated flow 
waves of corresponding peak flow. (a) Maximally effortful voluntary cough from a healthy volunteer 
(peak cough flow = 666 L/min, rise time = 0.05 sec, volume expelled = 3.5 L). (b) Mechanically 
generated flow burst (peak flow = 680 L/min, rise time = 0.03 sec, volume expelled = 1.6 L). (c) 
Maximally effortful voluntary cough from a subject with severely weakened cough following stroke 
(peak flow = 120 L/min, rise time = 0.14 sec, volume expelled = 0.4 L). (d) Mechanically generated 
flow burst (peak flow = 138 L/min, rise time = 0.04 sec, volume expelled = 0.2 L).  
 















































































































































































Figure 4. Coughs by healthy volunteers: The difference (pneumotachograph – alternative device) in 
measured peak cough flow (L/min) between pneumotachograph and (a) Mini-Wright peak flow meter, 
(b) Assess peak flow meter, (c) SpiroUSB spirometer and (d) Microlab spirometer is plotted against 
cough rise time (sec). Solid lines indicate the lines of equality (no difference between measurements).  
 















































































































































































Figure 5. Forced expiratory manoeuvres by healthy volunteers: Bland-Altman graphs of the 
agreement in measuring peak flow (L/min) between the pneumotachograph measurement system and 
(a) the Mini-Wright peak flow meter, (b) the Assess peak flow meter, (c) the SpiroUSB spirometer 
and (d) the Microlab spirometer. The difference between two measurements (pneumotachograph – 
alternative device) is plotted against the mean of two measurements. Solid lines indicate the lines of 
equality (no difference between measurements). Three dashed lines indicate the mean difference 
between measurements (bias) and the upper and lower 95% limits of agreement (bias ± 1.96SD).  
 















































































































































































Figure 6. Forced expiratory manoeuvres by healthy volunteers: The difference (pneumotachograph – 
alternative device) in measured peak flow (L/min) between pneumotachograph and (a) Mini-Wright 
peak flow meter, (b) Assess peak flow meter, (c) SpiroUSB spirometer and (d) Microlab spirometer is 
plotted against rise time (sec). Solid lines indicate the lines of equality (no difference between 
measurements).  
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